Randox Biosciences Resource Hub

Home - Resource

Randox Biosciences Resource Hub

Resource Hub | Biosciences

  • Brochures
  • Clinical Studies Group Publications
  • Flyers
  • Videos

Biosciences overview

Immunology

Proteomics- OLINK Technology

CDx & Biopharma Services

Molecular Testing

Genomics Services

Life Science Product List

Cardiovascular & Metabolic

Acute Kidney Injury

2019.Stratifying risk of acute kidney injury in pre and post cardiac surgery patients using a novel biomarker-based algorithm and clinical risk score

Stratifying risk of acute kidney injury in pre and post cardiac surgery patients using a novel biomarker-based algorithm and clinical risk score - 2019

2021.Blood and urinary cytokine balance and renal outcomes at cardiac surgery

Blood and urinary cytokine balance and renal outcomes at cardiac surgery - 2021

2020.Acute kidney injury risk in orthopaedic trauma patients pre and post surgery using a biomarker algorithm and clinical risk score

Acute kidney injury risk in orthopaedic trauma patients pre- and post-surgery using a biomarker algorithm and clinical risk score - 2020

2020.Stratifying-Risk-of-Acute-Kidney-Injury-in-Pre-and-Post-Cardiac-Surgery-Patients-Using-a-Novel-Biomarker-Based-Algorithm-and-Clinical-Risk-Score

Stratifying Risk of Acute Kidney Injury in Pre- and Post-Cardiac Surgery Patients Using a Novel Biomarker Based Algorithm and Clinical Risk Score - 2020

ARID

2022.Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization- Findings From the ASSESS-AKI and ARID Studies

Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization- Findings From the ASSESS-AKI and ARID Studies - 2022

Diabetic Nephropathy

_2021_Harkin_On_tissue_chemical_derivatization_in_mass_spectrometry_imaging

On tissue chemical derivatization in mass spectrometry imaging - 2021

2022.Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects A Case-Control Study to Identify Potential Biomar

Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects A Case-Control Study to Identify Potential Biomarkers - 2022

2023.Analysis of reactive aldehydes in urine and plasma of type-2 diabetes mellitus patients through liquid chromatography-mass spectrometry Reactive al

Analysis of reactive aldehydes in urine and plasma of type-2 diabetes mellitus patients through liquid chromatography-mass spectrometry: Reactive aldehydes as potential markers of diabetic nephropathy - 2023

HABIO

2019.op68-value-engineered-translation-an-example-for-bladder-cancer-diagnosis

op68 value engineered translation an example for bladder cancer diagnosis - 2019

2020.Thrombomodulin Expression in Bladder Cancer Tissue and Its Association with Prognosis and Patient Survival

Thrombomodulin Expression in Bladder Cancer Tissue and Its Association with Prognosis and Patient Survival - 2020

2022.Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific

Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific - 2022

2024.Stratifying risk of disease in haematuria patients using machine learning techniques to improve diagnostics

Stratifying risk of disease in haematuria patients using machine learning techniques to improve diagnostics - 2024

HABIO Diabetes

2020.Stratifying-Risk-of-Acute-Kidney-Injury-in-Pre-and-Post-Cardiac-Surgery-Patients-Using-a-Novel-Biomarker-Based-Algorithm-and-Clinical-Risk-Score

Clinical features and predictive biomarkers for bladder cancer in patients with type 2 diabetes presenting with haematuria - 2022

MACE

2022.A novel algorithm for cardiovascular screening using conjunctival microcirculatory parameters and blood biomarkers.pdf

A novel algorithm for cardiovascular screening using conjunctival microcirculatory parameters and blood biomarkers - 2022

MAST4Health

2018. The 9th Santorini Conference- Systems Medicine

The 9th Santorini Conference: Systems Medicine, Personalised Health and Therapy. “The Odyssey from Hope to Practice”, Santorini, Greece, 30 September – 3 October 2018

2018.The polymorphism rs6918289 located in the downstream region of the TREM2 gene is associated with TNF-α levels and IMT-F

The polymorphism rs6918289 located in the downstream region of the TREM2 gene is associated with TNF-α levels and IMT-F - 2018

2019.Peripheral blood mononuclear cells extracts VEGFprotein levels and VEGF mRNA- Associations with inflammatory molecules in a healthy population

Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population - 2019

2020.Epigenome-wide association study in healthy individuals identifies significant associations with DNA methylation and PBMC extract VEGF-A concentration

Epigenome-wide association study in healthy individuals identifies significant associations with DNA methylation and PBMC extract VEGF-A concentration - 2020

2021.A genetic determinant of VEGF-A levels is associated with telomere attrition

A genetic determinant of VEGF-A levels is associated with telomere attrition - 2021

2021.Epigenome-wide association study detects a novel loci associated with central obesity in healthy subjects

Epigenome‑wide association study detects a novel loci associated with central obesity in healthy subjects - 2021

2021.Nutrigenetic Interactions Might Modulate the Antioxidant and AntiInflammatory Status in MastihaSupplemented Patients With NAFLD

Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-inflammatory Status in Mastiha-Supplemented Patients With NAFLD - 2021

2022.Association of Dietary Patterns with MRI Markers of Hepatic Inflammation and Fibrosis in the MAST4HEALTH Study

Association of Dietary Patterns with MRI Markers of Hepatic Inflammation and Fibrosis in the MAST4HEALTH Study - 2022

2022.Epigenome-Wide Association Study (EWAS) of Blood Lipids in Healthy Population from STANISLAS Family Study (SFS)

Epigenome-Wide Association Study (EWAS) of Blood Lipids in Healthy Population from STANISLAS Family Study (SFS) - 2022

Myocardial Infarction

2018.diagnostic-performance-of-a-combination-biomarker-algorithm-for-ruleout-of-acute-myocardial-infarction-at-time-of-presentation-to-2155-9880-1000600

Diagnostic Performance of a Combination Biomarker Algorithm for Rule- Out of Acute Myocardial Infarction at Time of Presentation to the Emergency Department, Using Heart-Type Fatty Acid-Binding Protein and High-Sensitivity Troponin T tests - 2018

2019.AnAlgorithm Based on Combining hs-cTnT and H-FABP for Ruling Out Acute Myocardial Infarction

An Algorithm Based on Combining hs-cTnT and H-FABP for Ruling Out Acute Myocardial Infarction - 2019

NASH / NAFLD

2022.Non-alcoholic fatty liver disease—A pilot study investigating early inflammatory and fibrotic biomarkers of NAFLD with alcoholic liver disease

Non-alcoholic fatty liver disease—A pilot study investigating early inflammatory and fibrotic biomarkers of NAFLD with alcoholic liver disease - 2022

Polypharmacy

2019.THE INTENSITY AND IMPACT OF CHRONIC PAIN, A STORY OF DIFFICULTY SLEEPING AND POSTTRAUMATIC STRESS DISORDER

A review of the prescribing culture of anti-depressants across government districts in Northern Ireland - 2023

Post-Traumatic Stress Disorder

2019.THE INTENSITY AND IMPACT OF CHRONIC PAIN, A STORY OF DIFFICULTY SLEEPING AND POSTTRAUMATIC STRESS DISORDER

The Intensity and Impact of Chronic Pain, a Story of Difficulty Sleeping and Post-Traumatic Stress Disorder - 2019

2020.Sleep, a Governor of Morbidity in PTSD-A Systematic Review of Biological Markers in PTSDRelated Sleep Disturbances

Sleep, a Governor of Morbidity in PTSD: A Systematic Review of Biological Markers in PTSD-Related Sleep Disturbances - 2020

2021.Post-traumatic stress disorder- A biopsychosocial case-control study investigating peripheral blood protein biomarkers

Post-traumatic stress disorder: A biopsychosocial case-control study investigating peripheral blood protein biomarkers - 2021

2022.ABSTRACT.improving-sleep-in-a-population-at-high-risk-of-trauma-a-pilot-study-examining-self-reported-sleep-psychological-symptomology-and-actigraphy-measured-night-t

Improving sleep in a population at high risk of trauma: A pilot study examining self-reported sleep, psychological symptomology and actigraphy measured night-time sleep - 2022

2022.Post-traumatic stress disorder; identifying potential differences in participant response to CAPS-5 life events checklist questionnaire based on gender

Post-Traumatic Stress Disorder: Identifying Potential Differences in Participant Response to CAPS-5 Life Events Checklist Questionnaire Based on Gender - 2022

2023.Sleep Disturbances and Chronic Pain as Potential Indicators for Therapeutic Intervention in Subjects with Post-Traumatic Stress Disorder

Sleep Disturbances and Chronic Pain as Potential Indicators for Therapeutic Intervention in Subjects with Post-Traumatic Stress Disorder - 2023

2023. REVIEW. Post-Traumatic Stress Disorder- Sleep Disturbances and Biomarkers

Post-Traumatic Stress Disorder: Sleep Disturbances and Biomarkers - Review - 2023

Pre-eclampsia

2024.Feto-maternal indicators of cardiac dysfunction as a justification for the cardiac origins for pre-eclampsia

Feto-maternal indicators of cardiac dysfunction as a justification for the cardiac origins for pre-eclampsia - 2024

Prostate Cancer

2019.ABSTRACT.McNAlly_et_al_diagnostic_classifiers_for_stratifying_patients_at_risk_of_prostate_cancer

Diagnostic classifiers for stratifying patients at risk of prostate cancer - 2019

2020.Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer-A Literature Review

Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review - 2020

2022.A Novel Combination of Serum Markers in a Multivariate Model to Help Triage Patients Into “Low-” and “High-Risk” Categories for Prostate Cancer

A Novel Combination of Serum Markers in a Multivariate Model to Help Triage Patients Into “Low-” and “High-Risk” Categories for Prostate Cancer - 2022

Oncology

Randox & Transgene SS

Design and selection of anti-PD-L1 single-domain antibody and tumor necrosis factor superfamily ligands for an optimal vectorization in an oncolytic virus- 2023

Biosciences Bioreagents

Type 1 Diabetes Flyer

Biochip Array Technology

Rapid Stratification of ARDs Flyer

OMICS Services

APOE4 Flyer

Your Next Chosen Partner

Randox Bioreagents- MAbs

Drug Induced Kidney Injury panel

Randox Bioreagents Recombinant Proteins

Biochip Overview

Biosciences Overview Video

Randox Multiplex Stroke Biochip

Randox Bioreagents- Polyclonal Abs

Randox Bioreagents- Overview

STI Campaign Video

Acute Kidney Injury

Randox Coronavirus Biochip Video


Vivalytic Resource Hub

Vivalytic | Resource Hub

Making a Point to Care

 

  • Brochures
  • Flyers
  • Videos
  • Scientific Papers

Vivalytic

VIVALYTIC MG, MH UP/UU Educational Guide

VIVALYTIC MRSA/SA Educational Guide

Vivalytic Gastroenteritis Educational Guide

Vivalytic Bordetella Edu guide Cover

VIVALYTIC Bordetella Detection & Species Identification Educational Guide

Vivalytic Overview

Discover more about the Vivalytic

 

 

SARS-CoV-2 Dual Target, Flu A/B and RSV

SARS-CoV-2 Dual Target

MPXV (Monkeypox)

Urinary Tract Infection (UTI)

Candida auris

Viral Respiratory Infection Array

Sexually Transmitted Infection Array

C. difficile

Bacterial Meningitis

riTA CT/NG

SARS-CoV-2 Pooling Test

MG, MH, UP/UU Rapid Test

Norovirus

Bordetella

Monkeypox (MPXV)

SARS-CoV-2 Rapid Test

MRSA & MSSA Rapid Test

Rota-, Norovirus & C. difficile

Strep A

UTI For-Use Cases

Randox Vivalytic

Vivalytic Installation & Operator User Guide

Vivalytic: Instructional Promo Video

Vivalytic: COVID-19 Testing Process

Coronavirus Testing on the Vivalytic POC Analyser

EVALUATION OF A MULTIPLEX REAL-TIME PCR ASSAY FOR THE DIAGNOSIS OF SEXUALLY-TRANSMITTED INFECTIONS

RAPID AND ACCURATE DETECTION OF MYCOPLASMATACEAE IN CLINICAL SAMPLES

Rapid and Accurate Detection of Whooping Cough in Clinical Samples

Evaluation of the Vivalytic one Analyser for detecting uropathogenic bacteria and antimicrobial resistances in urine samples of urological patients


Randox QC Resource Hub

  • Brochures
  • Support Tools
  • Educational Items
  • Posters
  • Industry Articles
  • Webinars
  • Videos
  • Blog
  • Testimonials
The importance of third party controls brochure on the Randox Resource hub

Importance of Third Party Controls

Infectious Disease Controls (Serology)

IQC - Liquid 30 Day Controls

RIQAS Point of Care (RIQAS POC)

Qnostics - Molecular Infectious Disease Controls

QCMD - EQA for Molecular Infectious Disease Testing

International Brochures

Download our brochures in other languages

Serum Indices

The Role of Six Sigma in a Modern QC Strategy

The Cost of Poor Quality in the Clinical Laboratory

How to Establish QC Reference Ranges

Basic QC Statistics

ISO 15189 Requirements for Measurement Uncertainty

Commutability

How To Measure Uncertainty

Which QC is The Right QC - Downloads

Which QC is The Right QC

How Often Is Right For QC - Download

How Often Is Right For QC

The Role of EQA in QC

QC Statistics Infographic - Download

QC Statistics Infographic

The Difference Between IQC & EQA - Download

The Difference Between IQC & EQA

Linearity Verification Clinical Chemistry - Download

Linearity Verification Clinical Chemistry

Linearity Verification Cardiac - Download

Linearity Verification Cardiac

Using QC Multi-rules - Download

Using QC Multi-Rules

Preparing QC - Step-by-Step Guide - Download

Preparing QC - Step-by-Step Guide

Monitoring EQA Performance - Download

Monitoring EQA Performance

Guide to Running QC - Download

Guide to Running QC

RIQAS Frequency - Lipase

RIQAS Past Panels Flyer

Measurement Uncertainty in the Clinical Laboratory – Medical Buyer

Measurement Uncertainty in the Clinical Laboratory – Medical Buyer

Using Sigma metrics and Measurement Uncertainty in QC – MLO

Using Sigma metrics and Measurement Uncertainty in QC – MLO

Webinar: Acusera 24.7 - The Future of QC Data Management.

Webinar - Jesienne spotkanie z Wewnątrzlaboratoryjną Kontrolą Jakości

Webinar | RIQAS Report Interpretation & Troubleshooting `{`PART1`}`

Fully syndromic approach to molecular testing

RIQAS Report Interpretation

The Role of EQA in QC Management

Importance of EQA

The Need for Robust Molecular Quality Assurance in the Wake of the Pandemic

Acusera 24•7 Webinar: Utilisation of QC software and metrics to help identify performance issues

Medlab- 24.7 Webinar with Patrick Else

Importance of Third Party Controls in Molecular Diagnostics

Why is the third party QC important for COVID-19 detection in Molecular testing

SARS-CoV-2 Proficiency Testing

Performance & Statistics - How EQA Can Help You Excel

Smartdocs - How To Guide

Acusera Third Party Controls

True Third Party Controls

Acusera Serum Indices Control

Consolidation

QC Serology Video

Acusera 24.7 Live Online

Guide to Running Quality Control

Medical Lab Professionals Week 2016

Acusera 24•7 Interlaboratory Data Management

Acusera 247 Video

Randox Acusera Quality Controls

Customer Testimonial | Adrian Cudmore NHS

Customer Testimonial | DR Caje Moniz NHS

Customer Testimonial | Dr Rosa Sierra Amor

Customer Testimonial | Dr Bianca Thakkar

Customer Testimonial | Dr. Anil Shah

Customer Testimonial | Dr Pragati Desai

Customer Testimonial | Dr Pramod Ingale

Customer Testimonial | Dr Rajeev Mehta

Customer Testimonial | Dr Simple Bhuptani

Customer Testimonial | Dr SM Patel

Customer Testimonial | Dr Trupti Patel

Customer Testimonial | Dr A Vahed Mulla


Evidence Series Resource Hub

Evidence Series | Resource Hub

  • Brochures
  • Flyers
  • Videos
  • Blogs
  • Scientific Posters
  • Whitepapers

Evidence

Evidence Investigator

Evidence MultiSTAT

Evidence+

Evidence Evolution

Biochip Technology Explained

Evidence series Overview

Discover more about the Evidence series

 

Cytokines Flyer

DIKI Renal Flyer

A4 Renal Flyer

AKI Covid-19 Flyer

Evidence Investigator - Molecular Diagnostic Testing

Evidence MultiSTAT Demonstration

Evidence Evolution - World's Most Advanced Immunoanalyser

Evidence Investigator - Myco 9 Array, Step By Step

DEVELOPMENT OF A BIOCHIP ARRAY FOR THE SIMULTANEOUS DETECTION OF CANCER BIOMARKERS ON THE RANDOM ACCESS, FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

DEVELOPMENT OF A DUPLEX BIOCHIP ASSAY FOR THE SIMULTANEOUS DETECTION OF ANTI-THYROGLOBULIN AND ANTI-THYROID PEROXIDASE ANTIBODIES ON THE FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

DEVELOPMENT OF NEW BIOCHIP ARRAYS FOR THE DETERMINATION OF BIOMARKERS RELATED TO ACUTE KIDNEY INJURY APPLIED TO THE EVIDENCE INVESTIGATOR ANALYSER

DEVELOPMENT OF A NEW BIOCHIP BASED IMMUNOASSAY FOR THE DETECTION OF PARATHYROID HORMONE APPLIED TO THE EVIDENCE EVOLUTION ANALYSER

DEVELOPMENT OF A HIGHLY MULTIPLEXED MOLECULAR ASSAY FOR DETECTION OF INFECTION IN CF AIRWAYS

Repeatability and within-laboratory precision were assessed (n=80): Assay Repeatability Within-laboratory precision CV (%) CV (%) VCAM-1 4.5 6.8 ICAM-1 5.6 8.8 ESEL 12.8 16.6 PSEL 3.5 4.7 LSEL 5.7 8.2 17.096, 097.105RDRT DEVELOPMENT OF A BIOCHIP ARRAY FOR THE DETECTION OF ADHESION MOLECULES ON THE NEW RANDOM ACCESS FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

DEVELOPMENT OF A NEW BIOCHIP BASED IMMUNOASSAY UNAFFECTED BY DHEA-S INTERFERENCE FOR THE ACCURATE MEASUREMENT OF SERUM PROGESTERONE

DEVELOPMENT OF A BIOCHIP ARRAY FOR THE RAPID, SIMULTANEOUS DETECTION OF PEPSINOGEN I, PEPSINOGEN II AND GASTRIN 17, ON THE NEW RANDOM ACCESS, FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

CLINICAL EVALUATION OF A RAPID FULLY-AUTOMATED MULTIPLEX BIOCHIP ARRAY FOR STROKE DIAGNOSIS

DEVELOPMENT OF A NEW BIOCHIP ARRAY APPLIED TO THE NEW RANDOM ACCESS FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER FOR THE SIMULTANEOUS MEASUREMENT OF TSH, FREE T4 AND FREE T3

DEVELOPMENT OF A NEW BIOCHIP BASED IMMUNOASSAY FOR THE MEASUREMENT OF TOTAL 25-HYDROXYVITAMIN D IN SERUM AND THE ACCURATE CLASSIFICATION OF VITAMIN D STATUS

DEVELOPMENT OF A BIOCHIP ASSAY FOR THE DETECTION OF THYROXINE-BINDING GLOBULIN (TBG) ON THE NEW RANDOM ACCESS FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

GENETIC DIAGNOSIS OF MONOGENIC OR POLYGENIC FAMILIAL HYPERCHOLESTEROLEMIA IN NORTHERN IRELAND: EVALUATION OF THE RANDOX FH ARRAYS IN COMBINATION WITH THE RANDOX 6SNP POLYGENIC HYPERCHOLESTEROLEMIA ARRAY

DEVELOPMENT OF A BIOCHIP ARRAY FOR THE SIMULTANEOUS MEASUREMENT OF DISTINCT FATTY ACID-BINDING PROTEINS (FABPs)

DEVELOPMENT OF A NEW ENZYME-LINKED IMMUNOSORBENT ASSAY KIT TO DETECT NGAL IN HUMAN SERUM AND ITS APPLICATION TO CHRONIC KIDNEY DISEASE

SCREENING AND SELECTION OF ANTIBODIES FOR THE DETECTION OF MIP-1 ALPHA AND ITS APPLICATION TO THE STUDY OF CHRONIC KIDNEY DISEASE

DEVELOPMENT OF A 4-PLEX BIOCHIP ARRAY FOR THE EARLY DETECTION OF CHRONIC KIDNEY DISEASE

DEVELOPMENT OF A THIRD GENERATION TSH ASSAY ON THE NEW RANDOM ACCESS EVIDENCE EVOLUTION FULLY AUTOMATED BIOCHIP ANALYSER

APPLICATION OF THE NEW RANDOM ACCESS, FULLY AUTOMATED BIOCHIP ANALYSER EVIDENCE EVOLUTION TO SIMULTANEOUSLY MEASURE ANALYTES RELATED TO ENDOCRINE FUNCTION

STRATIFYING RISK OF ACUTE KIDNEY INJURY IN PRE AND POST CARDIAC SURGERY PATIENTS USING A NOVEL BIOMARKER-BASED ALGORITHM AND CLINICAL RISK SCORE

SARS-CoV-2 Vascular & Multi-System Dysfunction

Acute Kidney Injury and Antimicrobial Stewardship

Alzheimer's Disease, ApoE4 & Risk Detection


Randox Reagents Resource Hub

Resource Hub | Reagents

  • Brochures
  • Featured Reagents
  • Blogs
  • Webinars
  • Educational Items
Reagents Brochure

Reagents Brochure

Superior Performance & Unique Tests

Veterinary Diagnostic Solutions Brochure

Veterinary Diagnostic Solutions

Diabetes Portfolio Brochure

Diabetes Portfolio

Antioxidants Brochure

Antioxidants

Cardiology & Lipid Testing Brochure

Cardiology & Lipid Testing

Total Bile Acids Flyer

Total Bile Acids (5th Generation)

Specific Proteins Brochure

Specific Proteins

sdLDL-C Flyer

sdLDL-C

sdLDL-C Flyer

sdLDL-C (USA ONLY)

Reagents Brochure

Reagents Brochure - Spanish

Reagents Brochure

Reagents Brochure - French

Reagents Brochure

Reagents Brochure - Portuguese

Reagents Brochure

Reagents Brochure - Russian

Reagents Brochure

Reagents Brochure - Italian

Reagents Brochure

Reagents Brochure - Polish

Clinical Considerations in Evaluating Lipid Risk Beyond LDL-C

Presenter: Christie M Ballantyne, MD

Navigating the Gray Area of Atherosclerotic Risk Stratification A Roundtable Discussion

Navigating the Gray Area of Atherosclerotic Risk Stratification

Small-Dense LDL and Cardiovascular Disease

Cystatin C Whitepaper

Cystatin C

Early Risk Assessment of Renal Impairment using the Biomarker Cystatin C

OVERCOMING THE CURRENT CHALLENGES IN LP(A) MEASUREMENT

Lipoprotein(a)

Overcoming The Current Challenges in Lp(a) Measurement

sdLDL-C

Size Matters: The True Weight of Risk in Lipid Profiling


RX Series Resource Hub

RX series | Resource Hub

  • Brochures
  • International Brochures
  • Educational
  • Flyers
  • International Flyers
  • Videos
  • Blogs
  • Scientific Posters
  • Testimonials

RX series Overview

RX misano

RX monaco

RX daytona +

RX imola

RX modena

RX series Overview

Discover more about the RX series

Espanoi RX series Overview

Espanoi RX misano

Espanoi RX monaco

Espanoi RX daytona +

Espanoi RX imola

Espanoi RX modena

Polski RX series overview

Polski RX misano

Polski RX monaco

Polski RX daytona +

Polski RX imola

Polski RX modena

LT790POL

Polski RX series & Randox Reagents

Francais RX series overview

Russian RX series overview

RX modena, for measurement of Lipid Profile Tes